Duplicate vaginal swabs were obtained from patients who attended obstetric or gynecologic clinics affiliated with the Magee Womens Hospital in Pittsburgh. One swab was cultured semiquantitatively on 5 % sheep blood agar to detect group B streptococci (GBS). The other swab was subjected to a rapid method (25 min) for antigen detection and micronitrous acid exposure to extract the GBS antigen, followed by latex particle agglutination. A total of 464 swabs were evaluated by direct plating. Fifty-two swabs (11.2%) were found to contain GBS. Overall, the rapid method detected 21 of 52, or 40.4%, positive specimens. The sensitivity of the rapid method for identifying the most heavily colonized samples was 85.7%. This method can be used to identify maternity patients who are heavily colonized with GBS and are at high risk of delivering septic infants.
Group B streptococci (GBS) are the major cause of infectious neonatal morbidity and mortality. Maternal vaginal colonization provides the major reservoir of GBS from which neonatal colonization and infection derive during parturition (1, 2) . Recent investigations have shown that intrapartum antibiotics administered to mothers with vaginal colonization prevent neonatal colonization and early-onset sepsis with GBS (3, 4, 7, 9 ; N. Tuppurainen, K. Osterlund, and M. Hallman, Pediatr. Res. 20: 403A, 1986 ). Effective implementation of this strategy would be facilitated if there was a rapid method of identifying women colonized with GBS just before delivery. This study was undertaken to determine whether methods analogous to those used to rapidly identify group A streptococci directly from pharyngeal swabs (micronitrous acid extraction and latex particle agglutination [LPA]) can be effectively applied to the rapid identification of GBS directly from vaginal swabs.
Duplicate vaginal swabs were collected from women attending private or clinic obstetric and gynecologic offices between March and August of 1986. The specimens were collected by using rayon swabs (Culturette; Marion Scientific Corp., Kansas City, Mo.) and transported to the laboratory. Some swabs were processed immediately, and others were refrigerated at 4°C until processed. Using the Bactigen kit for group B streptococcus (Wampole Laboratories), we placed 50 of the supernatant in each of two wells on a glass serologic slide. This specimen was processed as directed in the package insert, save for the elimination of the specimen-absorbent step, the need for which was obviated by the previous centrifugation procedure. A 10-p1i volume of GBS reagent latex was added to one well, and 10 jil of GBS control latex was added to the other. The agglutination reaction pattern was read as positive when dense, white clumps were seen against a clear background; the reactions were always easily interpreted.
To test the sensitivity of this method, 200 of decreasing 10-fold dilutions of a 5-h growth of GBS suspension was absorbed by a Culturette swab and extracted. The In contrast to the need for high sensitivity in identifying individuals who are ill with group A streptococci, methods for the rapid identification of GBS vaginal carriers need only identify the group of women who are heavily colonized. Jones et al. (5) have shown that, almost exclusively, heavily colonized maternity patients delivered heavily colonized infants who, in turn, were at increased risk for developing GBS disease. Antigen detection methods used by Jones et al. (5) and Lim et al. (7) identified percentages of heavily colonized GBS vaginal carriers similar to those which we detected (25, 28, and 40%, respectively). Furthermore, their methods were sufficiently sensitive to identify the motherinfant pairs who were at risk for neonatal GBS sepsis. The advantage of the method of rapid detection described herein is that the results are available within 20 to 30 min of obtaining the vaginal specimen; the procedure does not involve the 5 to 7 h of incubation and processing required by other methods.
Of the 464 swabs, 3 were found to be antigen positive but culture negative. These false-positive reactions may have been caused by other normal vaginal flora which may contain cross-reacting surface antigens or by staphylococci which can cause nonspecific agglutination patterns. Alternatively, unknown antibiotic use by study subjects may have invalidated the culture results.
In two cases of heavy colonization (4+), the rapid method failed to identify the specimen as GBS antigen positive. In each instance, the swab which had been used for the culture was tested for antigen. One was found to be positive, and the other was found to be negative. Since separate swabs were routinely used for culturing and antigen detection, these discordant results may represent sampling error rather than an inadequacy of the antigen detection technique.
Micronitrous acid extraction and LPA can rapidly identify maternity patients with heavy vaginal colonization by GBS who are at high risk of delivering septic infants. Slifkin et al. (8) previously evaluated a similar method using noncommercial extraction reagents and a Phadebact coagglutination technique, but the procedure was cumbersome and not easily adaptable to a clinical laboratory. The ease of performance and interpretation and the rapidity of the test procedure presented here allow timely implementation of intrapartum chemoprophylaxis. The availability of test results in 25 min permits evaluation of those parturients who deliver prematurely (a group which would otherwise elude third-trimester prenatal cultures) or precipitously (a group which would deliver before initiation of chemoprophylaxis based on the results of antigen detection methods requiring a 5-to 7-h period of incubation and processing).
